Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6.
A key step in gene therapy is the efficient transfer of genes in a cell type- and tissue-specific manner. To better understand the mechanism of adeno-associated virus serotype 6 (AAV6) transduction, we used comparative gene analysis (CGA) combined with pathway visualization software to identify a positive correlation between AAV6 transduction and epidermal growth factor receptor (EGFR) expression. Subsequent experiments suggested that EGFR is necessary for vector internalization and probably functions as a co-receptor for AAV6.
Weller
Melodie L
ML
Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, US National Institutes of Health (NIH), Bethesda, Maryland, USA.
Amornphimoltham
Panomwat
P
Schmidt
Michael
M
Wilson
Paul A
PA
Gutkind
J Silvio
JS
Chiorini
John A
JA
D000818:Animals; D045744:Cell Line, Tumor; D000229:Dependovirus / Q000235:genetics / Q000502:physiology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D005260:Female; D000077156:Gefitinib; D015870:Gene Expression / Q000235:genetics / Q000502:physiology; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors / Q000235:genetics; D006258:Head and Neck Neoplasms / Q000628:therapy; D007519:Isoantigens; D051379:Mice; D008819:Mice, Nude; D009374:Neoplasms, Experimental / Q000628:therapy; D011799:Quinazolines / Q000494:pharmacology; D011991:Receptors, Virus / Q000235:genetics / Q000502:physiology*; D014161:Transduction, Genetic; D020032:Tyrphostins / Q000494:pharmacology
D007519:Isoantigens; D011799:Quinazolines; D011991:Receptors, Virus; D020032:Tyrphostins; C067704:neutrophil-specific antigen NA1, human; C101044:RTKI cpd; D066246:ErbB Receptors; D000077156:Gefitinib
Mol Ther. 2004 Oct;10(4):671-8
15451451
Hum Gene Ther. 2007 Apr;18(4):344-54
17430088
Nat Med. 2003 Oct;9(10):1306-12
14502277
Trends Microbiol. 2008 May;16(5):208-14
18406140
J Virol. 2006 May;80(10):5082-5
16641301
Hum Gene Ther. 2005 Feb;16(2):178-86
15761258
Br J Cancer. 2002 May 6;86(9):1518-23
11986789
J Virol. 2000 Feb;74(3):1524-32
10627564
Hum Gene Ther. 1996 Nov 10;7(17):2101-12
8934224
Mol Ther. 2008 Jun;16(6):1073-80
18414476
Mol Ther. 2007 Jul;15(7):1323-30
17440440
Hum Gene Ther. 2005 Mar;16(3):381-92
15812233
J Virol. 1998 Dec;72(12):9835-43
9811719
Anticancer Drugs. 2008 Sep;19(8):783-8
18690089
Int J Clin Oncol. 2007 Apr;12(2):99-110
17443277